<?xml version='1.0' encoding='utf8' standalone='yes'?>
<collection><document><id>7011107</id><passage><infon key="name_1">surname:Chun;given-names:Byung Chul</infon><infon key="article-id_pmid">32023775</infon><infon key="name_0">surname:Ryu;given-names:Sukhyun</infon><infon key="year">2020</infon><infon key="article-id_pmc">7011107</infon><infon key="article-id_publisher-id">epih-42-e2020006</infon><infon key="article-id_doi">10.4178/epih.e2020006</infon><infon key="type">front</infon><infon key="elocation-id">e2020006</infon><infon key="volume">42</infon><infon key="license">This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</infon><infon key="section_type">TITLE</infon><infon key="journal">Epidemiol Health. 2020;42:e2020006. doi: 10.4178/epih.e2020006. Epub 2020 Feb 6.</infon><infon key="kwd">Coronavirus Epidemiology Characteristics Public health</infon><infon key="authors">Ryu S, Chun BC</infon><offset>0</offset><text>An interim review of the epidemiological characteristics of 2019 novel coronavirus</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>83</offset><text>OBJECTIVES</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>94</offset><text>The 2019 novel coronavirus (2019-nCoV) from Wuhan, China is currently recognized as a public health emergency of global concern.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>223</offset><text>METHODS</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>231</offset><text>We reviewed the currently available literature to provide up-to-date guidance on control measures to be implemented by public health authorities.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>377</offset><text>RESULTS</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>385</offset><text>Some of the epidemiological characteristics of 2019-nCoV have been identified. However, there remain considerable uncertainties, which should be considered when providing guidance to public health authorities on control measures.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>615</offset><text>CONCLUSIONS</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>627</offset><text>Additional studies incorporating more detailed information from confirmed cases would be valuable.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>726</offset><text>INTRODUCTION</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>739</offset><text>Several clusters of patients with pneumonia of unknown etiology in Wuhan, Hubei Province, China were reported to the Chinese health authorities starting on December 8, 2019, and most of these cases were epidemiologically linked to a local fish and animal market. The pathogenic agent responsible for these clusters of pneumonia was identified as a 2019 novel coronavirus (2019-nCoV). At the very beginning of the 2019-nCoV outbreak in China, much remained unknown, except for the fact that it was transmitted by direct exposure at the market. However, person-to-person transmission of 2019-nCoV has been confirmed, and asymptomatic individuals have been identified as potential sources of infection. The number of identified cases has been steadily growing, and as of February 3, a total of 14,557 cases had been reported globally (14,411 in China and 146 in 22 other countries). Since the first laboratory-confirmed case was identified on January 20, 2020 in Korea, the number of reported cases grew to 15 as of February 3, 2020 (Figure 1 and Table 1).</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1793</offset><text>There remain considerable knowledge gaps on 2019-nCoV; therefore, the public health authorities in countries with any likelihood of experiencing imported cases of 2019-nCoV should update the case definition to reflect newly updated epidemiological data. Herein, we present a review of the literature on the epidemiological characteristics of human infections with 2019-nCoV to provide an interim summary to public health authorities.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>2227</offset><text>MATERIALS AND METHODS</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>2249</offset><text>We searched the literature for studies reporting epidemiological characteristics of 2019-nCoV, including the reproductive number, incubation period, serial interval, infectious period, generation time, latent period, and the fatality rate of hospitalized cases. The Korean Society of Epidemiology 2019-nCoV Task Force Team (KSE 2019-nCoV TFT) searched for peer-reviewed articles published from December 8, 2019 to February 1, 2020. Articles were eligible for inclusion if they reported any epidemiological characteristics of 2019-nCoV.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>2785</offset><text>Ethics statement</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>2802</offset><text>The ethical approval or individual consent was not applicable.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>2865</offset><text>RESULTS</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>2873</offset><text>Six articles were identified and included in this review (Table 2) . Four relevant studies estimated the reproductive number. A study of confirmed cases from Wuhan, China estimated the reproductive number to be 1.9 (95% confidence interval [CI], 1.3 to 3.2). Three other studies estimated the mean reproductive number as 0.3, 2.2, and 2.68, respectively. A study reported the mean incubation period to be 6.1 days (95% CI, 3.8 to 9.7), and the mean serial interval to be 7.7 days (95% CI, 4.9 to 13.0). Two studies predicted the mean doubling time to be between 6.4 days and 8.7 days. Three studies estimated the fatality rate of hospitalized cases as 14-15%. We could not identify any studies that reported the infectious and latent periods.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>3616</offset><text>DISCUSSION</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>3627</offset><text>We reviewed the epidemiological characteristics of 2019-nCoV. The estimated reproductive number of 0.3 was obtained from a small number of infected persons with imperfect information in the very early stages of the outbreak; therefore the reproductive number of 2019-nCoV is likely to be similar to that of the 2002/2003 severe acute respiratory syndrome (SARS) coronavirus during the pre-intervention period (range, 2 to 3) and that of the 2009 pandemic A/H1N1 influenza virus in the United States (range, 1.3 to 1.7). The incubation period is likely similar to that of the SARS coronavirus, but with a wider confidence interval (mean, 4.8 days; 95% CI, 4.2 to 5.5). Furthermore, it is longer than that of the 2009 pandemic A/H1N1 influenza virus (median incubation period, 1.4 days; 95% CI, 1.0 to 1.8). Therefore, the evidence reviewed above shows that the current control measures for 2019-nCoV, including a quarantine and observation period of 14 days for suspected cases, can be considered appropriate. The generation time and serial interval of 2019-nCoV are longer than those of the 2009 pandemic A/H1N1 influenza virus (median generation time, 2.7 days; 95% CI, 2.0 to 3.5; and mean serial interval: range, 2.6 to 3.2). However, the mean serial interval of 2019-nCoV is similar to that of the SARS coronavirus (mean, 8.4 days; standard deviation, 3.8). The overall case fatality rate of 2019-nCoV was estimated by international experts to range from 3% to 14%, and it is more likely to cause infection in older age groups with commodities.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>5176</offset><text>Epidemiological parameters are usually obtained from a consecutive timeline of the number of reported cases and contact-tracing data. However, most of the studies included in our review made estimates using data obtained from the early stages of the outbreak in Wuhan, in which the reporting of confirmed cases may have been incomplete. Furthermore, differences in the simulation methodology used in various scenarios may result in a wide spectrum of estimated values. Therefore, caution is needed when interpreting these reported results.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>5716</offset><text>The number of confirmed cases is increasing in China and in other countries, including Korea. Furthermore, the likelihood of local transmission is increasing as a result of cases entering from China.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>5916</offset><text>In light of a report describing a case of human-to-human transmission in the asymptomatic period, it is necessary to consider updating the case definition for surveillance; however, more detailed studies presenting evidence on the epidemiological nature, clinical presentation, and pathogenesis of 2019-nCoV are necessary to provide information for public health decision-making.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">footnote</infon><offset>6296</offset><text>The authors have no conflicts of interest to declare for this study.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">footnote</infon><offset>6365</offset><text>FUNDING </text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">footnote</infon><offset>6374</offset><text>None.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">footnote</infon><offset>6380</offset><text>AUTHOR CONTRIBUTIONS</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">footnote</infon><offset>6401</offset><text>Conceptualization: BCC, SR. Data curation: KSE 2019-nCoV TFT. Formal analysis: BCC, SR. Methodology: BCC, SR. Writing - original draft : BCC, SR. Writing - review &amp; editing: BCC, KSE 2019-nCoV TFT, SR.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title_1</infon><offset>6603</offset><text>SUPPLEMENTARY MATERIALS</text></passage><passage><infon key="section_type">REF</infon><infon key="type">title</infon><offset>6627</offset><text>REFERENCES</text></passage><passage><infon key="name_3">surname:Li;given-names:X</infon><infon key="name_2">surname:Wang;given-names:W</infon><infon key="name_1">surname:Zhang;given-names:D</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Zhu;given-names:N</infon><infon key="pub-id_doi">10.1056/NEJMoa2001017</infon><infon key="year">2020</infon><infon key="source">N Engl J Med</infon><infon key="type">ref</infon><infon key="name_5">surname:Song;given-names:J</infon><infon key="name_4">surname:Yang;given-names:B</infon><offset>6638</offset><text>A novel coronavirus from patients with pneumonia in China, 2019</text></passage><passage><infon key="name_3">surname:Qu;given-names:J</infon><infon key="name_2">surname:Dong;given-names:X</infon><infon key="name_1">surname:Zhou;given-names:M</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Chen;given-names:N</infon><infon key="pub-id_doi">10.1016/S0140-6736(20)30211-7</infon><infon key="year">2020</infon><infon key="source">Lancet</infon><infon key="type">ref</infon><infon key="name_5">surname:Han;given-names:Y</infon><infon key="name_4">surname:Gong;given-names:F</infon><offset>6702</offset><text>Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study</text></passage><passage><infon key="volume">395</infon><infon key="section_type">REF</infon><infon key="fpage">311</infon><infon key="pub-id_pmid">31986259</infon><infon key="year">2020</infon><infon key="source">Lancet</infon><infon key="type">ref</infon><offset>6832</offset><text>Emerging understandings of 2019-nCoV</text></passage><passage><infon key="name_3">surname:To;given-names:KK</infon><infon key="name_2">surname:Kok;given-names:KH</infon><infon key="name_1">surname:Yuan;given-names:S</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Chan;given-names:JF</infon><infon key="pub-id_doi">10.1016/S0140-6736(20)30154-9</infon><infon key="year">2020</infon><infon key="source">Lancet</infon><infon key="type">ref</infon><infon key="name_5">surname:Yang;given-names:J</infon><infon key="name_4">surname:Chu;given-names:H</infon><offset>6869</offset><text>A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster</text></passage><passage><infon key="name_3">surname:Bretzel;given-names:G</infon><infon key="name_2">surname:Sothmann;given-names:P</infon><infon key="name_1">surname:Schunk;given-names:M</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Rothe;given-names:C</infon><infon key="pub-id_doi">10.1056/NEJMc2001468</infon><infon key="year">2020</infon><infon key="source">N Engl J Med</infon><infon key="type">ref</infon><infon key="name_5">surname:Wallrauch;given-names:C</infon><infon key="name_4">surname:Froeschl;given-names:G</infon><offset>7014</offset><text>Transmission of 2019-nCoV infection from an asymptomatic contact in Germany</text></passage><passage><infon key="section_type">REF</infon><infon key="comment">[cited 2020 Feb 3]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports</infon><infon key="type">ref</infon><offset>7090</offset><text>Novel Coronavirus (2019-nCoV) situation reports</text></passage><passage><infon key="section_type">REF</infon><infon key="comment">[cited 2020 Feb 3]. Available from :http://ncov.mohw.go.kr/tcmBoardList.do?brdId=&amp;brdGubun=&amp;dataGubun=&amp;ncvContSeq=&amp;contSeq=&amp;board_id=(Korean)</infon><infon key="type">ref</infon><offset>7138</offset><text>2019-nCoV</text></passage><passage><infon key="name_3">surname:Wong;given-names:JY</infon><infon key="volume">25</infon><infon key="name_2">surname:Lau;given-names:EH</infon><infon key="name_1">surname:Hao;given-names:X</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Wu;given-names:P</infon><infon key="fpage">2000044</infon><infon key="year">2020</infon><infon key="source">Euro Surveill</infon><infon key="type">ref</infon><infon key="name_5">surname:Wu;given-names:JT</infon><infon key="name_4">surname:Leung;given-names:KS</infon><offset>7148</offset><text>Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020</text></passage><passage><infon key="name_3">surname:Ren;given-names:L</infon><infon key="name_2">surname:Li;given-names:X</infon><infon key="name_1">surname:Wang;given-names:Y</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Huang;given-names:C</infon><infon key="pub-id_doi">10.1016/S0140-6736(20)30183-5</infon><infon key="year">2020</infon><infon key="source">Lancet</infon><infon key="type">ref</infon><infon key="name_5">surname:Hu;given-names:Y</infon><infon key="name_4">surname:Zhao;given-names:J</infon><offset>7289</offset><text>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</text></passage><passage><infon key="name_3">surname:Wang;given-names:X</infon><infon key="name_2">surname:Wu;given-names:P</infon><infon key="name_1">surname:Guan;given-names:X</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Li;given-names:Q</infon><infon key="pub-id_doi">10.1056/NEJMoa2001316</infon><infon key="year">2020</infon><infon key="source">N Engl J Med</infon><infon key="type">ref</infon><infon key="name_5">surname:Tong;given-names:Y</infon><infon key="name_4">surname:Zhou;given-names:L</infon><offset>7372</offset><text>Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia</text></passage><passage><infon key="name_2">surname:Leung;given-names:GM</infon><infon key="name_1">surname:Leung;given-names:K</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Wu;given-names:JT</infon><infon key="pub-id_doi">10.1016/S0140-6736(20)30260-9</infon><infon key="year">2020</infon><infon key="source">Lancet</infon><infon key="type">ref</infon><offset>7457</offset><text>Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study</text></passage><passage><infon key="volume">25</infon><infon key="name_1">surname:Althaus;given-names:CL</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Riou;given-names:J</infon><infon key="fpage">2000058</infon><infon key="year">2020</infon><infon key="source">Euro Surveill</infon><infon key="type">ref</infon><offset>7605</offset><text>Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020</text></passage><passage><infon key="volume">160</infon><infon key="name_1">surname:Teunis;given-names:P</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Wallinga;given-names:J</infon><infon key="fpage">509</infon><infon key="pub-id_pmid">15353409</infon><infon key="year">2004</infon><infon key="source">Am J Epidemiol</infon><infon key="type">ref</infon><infon key="lpage">516</infon><offset>7725</offset><text>Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures</text></passage><passage><infon key="name_3">surname:Basta;given-names:NE</infon><infon key="name_2">surname:Halloran;given-names:ME</infon><infon key="name_1">surname:Sugimoto;given-names:JD</infon><infon key="name_0">surname:Yang;given-names:Y</infon><infon key="fpage">729</infon><infon key="pub-id_pmid">19745114</infon><infon key="year">2009</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">326</infon><infon key="section_type">REF</infon><infon key="lpage">733</infon><infon key="name_5">surname:Matrajt;given-names:L</infon><infon key="name_4">surname:Chao;given-names:DL</infon><offset>7832</offset><text>The transmissibility and control of pandemic influenza A (H1N1) virus</text></passage><passage><infon key="section_type">REF</infon><infon key="year">2020</infon><infon key="comment">[cited 2020 Feb 3]. Available from: https://www.ecdc.europa.eu/en/publications-data/risk-assessment-outbreak-acute-respiratory-syndrome-associated-novel-1</infon><infon key="type">ref</infon><offset>7902</offset><text>Risk assessment: outbreak of acute respiratory syndrome associated with a novel coronavirus, China: first local transmission in the EU/EEA - third update</text></passage><passage><infon key="volume">10</infon><infon key="name_1">surname:Tam;given-names:W</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Wong;given-names:TW</infon><infon key="fpage">1503</infon><infon key="pub-id_pmid">15503397</infon><infon key="year">2004</infon><infon key="source">Emerg Infect Dis</infon><infon key="type">ref</infon><infon key="lpage">1504</infon><offset>8058</offset><text>Estimating SARS incubation period</text></passage><passage><infon key="name_3">surname:Nair;given-names:HP</infon><infon key="name_2">surname:Cummings;given-names:DA</infon><infon key="name_1">surname:Reich;given-names:NG</infon><infon key="name_0">surname:Lessler;given-names:J</infon><infon key="fpage">2628</infon><infon key="pub-id_pmid">20042754</infon><infon key="year">2009</infon><infon key="source">N Engl J Med</infon><infon key="type">ref</infon><infon key="volume">361</infon><infon key="section_type">REF</infon><infon key="lpage">2636</infon><infon key="name_4">surname:Jordan;given-names:HT</infon><offset>8092</offset><text>Outbreak of 2009 pandemic influenza A (H1N1) at a New York City school</text></passage><passage><infon key="name_3">surname:Bajardi;given-names:P</infon><infon key="name_2">surname:Goncalves;given-names:B</infon><infon key="name_1">surname:Hu;given-names:H</infon><infon key="name_0">surname:Balcan;given-names:D</infon><infon key="fpage">45</infon><infon key="pub-id_pmid">19744314</infon><infon key="year">2009</infon><infon key="source">BMC Med</infon><infon key="type">ref</infon><infon key="volume">7</infon><infon key="section_type">REF</infon><infon key="name_5">surname:Ramasco;given-names:JJ</infon><infon key="name_4">surname:Poletto;given-names:C</infon><offset>8163</offset><text>Seasonal transmission potential and activity peaks of the new influenza A(H1N1): a Monte Carlo likelihood analysis based on human mobility</text></passage><passage><infon key="name_3">surname:Robins;given-names:JM</infon><infon key="name_2">surname:Cooper;given-names:B</infon><infon key="name_1">surname:Cohen;given-names:T</infon><infon key="name_0">surname:Lipsitch;given-names:M</infon><infon key="fpage">1966</infon><infon key="pub-id_pmid">12766207</infon><infon key="year">2003</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">300</infon><infon key="section_type">REF</infon><infon key="lpage">1970</infon><infon key="name_5">surname:James;given-names:L</infon><infon key="name_4">surname:Ma;given-names:S</infon><offset>8302</offset><text>Transmission dynamics and control of severe acute respiratory syndrome</text></passage><passage><infon key="name_3">surname:Gao;given-names:GF</infon><infon key="name_2">surname:Hayden;given-names:FG</infon><infon key="name_1">surname:Horby;given-names:PW</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Wang;given-names:C</infon><infon key="pub-id_doi">10.1016/S0140-6736(20)30185-9</infon><infon key="year">2020</infon><infon key="source">Lancet</infon><infon key="type">ref</infon><offset>8373</offset><text>A novel coronavirus outbreak of global health concern</text></passage><passage><infon key="name_3">surname:Tomba;given-names:GS</infon><infon key="name_2">surname:Birrell;given-names:PJ</infon><infon key="name_1">surname:Presanis;given-names:AM</infon><infon key="name_0">surname:De Angelis;given-names:D</infon><infon key="fpage">83</infon><infon key="pub-id_pmid">25843390</infon><infon key="year">2015</infon><infon key="source">Epidemics</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="section_type">REF</infon><infon key="lpage">87</infon><infon key="name_4">surname:House;given-names:T</infon><offset>8427</offset><text>Four key challenges in infectious disease modelling using data from multiple sources</text></passage><passage><infon key="section_type">FIG</infon><infon key="file">epih-42-e2020006f1.jpg</infon><infon key="id">f1-epih-42-e2020006</infon><infon key="type">fig_caption</infon><offset>8512</offset><text>Timeline of individuals with laboratory-confirmed 2019 novel coronavirus infections in Korea, as of February 3, 2020.</text></passage><passage><infon key="section_type">TABLE</infon><infon key="file">t1-epih-42-e2020006.xml</infon><infon key="id">t1-epih-42-e2020006</infon><infon key="type">table</infon><offset>8630</offset><text>Case No. Age (yr) Sex Nationality Date of entry to Korea Suspected infection of place or origin #1 35 Female Chinese Jan 19, 2020 Wuhan, China #2 55 Male Korean Jan 22, 2020 Wuhan, China #3 54 Male Korean Jan 20, 2020 Wuhan, China #4 55 Male Korean Jan 20, 2020 Wuhan, China #5 33 Male Korean Jan 24. 2020 Wuhan, China #6 55 Male Korean - Case #3 #7 28 Male Korean Jan 23, 2020 Wuhan, China #8 62 Female Korean Jan 23, 2020 Wuhan, China #9 28 Female Korean - Case #5 #10 54 Female Korean - Case #6 #11 25 Male Korean - Case #6 #12 48 Male Chinese Jan 19, 2020 Osaka, Japan #13 28 Male Korean Jan 31, 2020 Wuhan, China #14 40 Female Chinese - Case #12 #15 43 Male Korean Jan 20, 2020 Wuhan, China </text></passage><passage><infon key="section_type">TABLE</infon><infon key="file">t1-epih-42-e2020006.xml</infon><infon key="id">t1-epih-42-e2020006</infon><infon key="type">table_caption</infon><offset>9327</offset><text>List of confirmed cases of 2019 novel coronavirus infection in Korea, as of February 3, 2020</text></passage><passage><infon key="section_type">TABLE</infon><infon key="file">t2-epih-42-e2020006.xml</infon><infon key="id">t2-epih-42-e2020006</infon><infon key="type">table</infon><offset>9420</offset><text>Study Study setting Reproductive (n) Incubation period (d) Serial interval (d) Infectious period Doubling time (d) Latent period Fatality rate among hospitalized cases (%) Wu et al.  Publicly-available data in China as at Jan 22, 2020 0.30 (95% CI: 0.17, 0.44) NA NA NA NA NA 14.0 (95% CI: 3.9, 32.0) Huang et al.  41 confirmed cases admitted to a designated hospital in Wuhan by Jan 2, 2020 NA NA NA NA NA NA 15.0 Chen et al.  99 confirmed cases admitted in Wuhan Jinyintan Hosptial between Jan 1 and Jan 20, 2020 NA NA NA NA NA NA 14.6 Li et al.  425 confirmed cases in Wuhan as at Jan 22, 2020 1.9 (95% CI: 1.3, 3.2) 6.1 (95% CI: 3.8, 9.7) 7.7 (95% CI: 4.9, 13.0) NA 8.7 (95% CI: 4.8, 17.0) NA NA Riou et al.  Modelling study 2.2 (90% CI: 1.4, 3.8) NA NA NA NA NA NA Wu et al.  Modeling study 2.68 (95% CrI: 2.47, 2.86) NA NA NA 6.4 (95% CrI: 5.8, 7.1) NA NA </text></passage><passage><infon key="section_type">TABLE</infon><infon key="file">t2-epih-42-e2020006.xml</infon><infon key="id">t2-epih-42-e2020006</infon><infon key="type">table_caption</infon><offset>10283</offset><text>Summary of reviews included in the study</text></passage><passage><infon key="section_type">TABLE</infon><infon key="file">t2-epih-42-e2020006.xml</infon><infon key="id">t2-epih-42-e2020006</infon><infon key="type">table_footnote</infon><offset>10324</offset><text>CI, confidence interval; Crl, credible interval; NA, not available.</text></passage></document>
</collection>